Insider Trading: Allergan Inc (AGN.N)

AGN.N on New York Stock Exchange

190.55USD
11:32am EDT
Price Change (% chg)

$1.11 (+0.59%)
Prev Close
$189.44
Open
$190.00
Day's High
$191.07
Day's Low
$189.46
Volume
71,177
Avg. Vol
304,612
52-wk High
$192.60
52-wk Low
$88.34

Search Stocks
Gangolli Julian S Options Exercised: 353
Trade Date: Sunday, 30 Dec 2012 Price: 91.73
Title: Officer Shares Held: 28,235
Type Traded: Direct Net Change in Shares This Filing: -353

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 971
Total Shares Held: 307,667,420
3 Mo. Net Change: 342,303
# New Positions: 25
# Closed Positions: 20
# Increased Positions: 85
# Reduced Positions: 118
# Net Buyers: -33

Officers & Directors

Name Age Since Current Position

David Pyott

60 2013 Chairman of the Board, Chief Executive Officer, Principal Executive Officer

Douglas Ingram

51 2013 President

James Hindman

47 2014 Chief Financial Officer, Executive Vice President - Finance and Business Development

Scott Whitcup

54 2009 Executive Vice President - Research & Development, Chief Scientific Officer

Arnold Pinkston

55 2011 Executive Vice President, General Counsel, Assistant Secretary

Scott Sherman

48 2010 Executive Vice President - Human Resources

Raymond Diradoorian

56 2006 Executive Vice President - Global Technical Operations

James Barlow

55 2005 Senior Vice President, Corporate Controller, Principal Accounting Officer

Julian Gangolli

56 2011 Corporate Vice President and President, North America

Michael Gallagher

68 2013 Lead Independent Director

Henri Termeer

68 2014 Director

Deborah Dunsire

51 2006 Independent Director

Trevor Jones

71 2004 Independent Director

Louis Lavigne

65 2005 Independent Director

Peter McDonnell

55 2013 Independent Director

Timothy Proctor

64 2013 Independent Director

Russell Ray

66 2003 Independent Director

Jim Hindman

IR Contact Officer
Search Stocks